Cordlife Group Limited (CLIFF)
USD 0.12
(-8.61%)
USD 0.12
(-8.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 37.3 Million SGD | 0.31% |
| 2022 | 37.18 Million USD | 30.18% |
| 2021 | 28.56 Million SGD | -2.88% |
| 2020 | 29.41 Million SGD | 2.81% |
| 2019 | 28.6 Million SGD | -21.41% |
| 2018 | 36.4 Million SGD | -20.45% |
| 2017 | 45.76 Million SGD | 21.91% |
| 2016 | 37.53 Million SGD | -3.08% |
| 2015 | 38.73 Million SGD | 31.04% |
| 2014 | 29.55 Million SGD | -15.21% |
| 2013 | 34.85 Million SGD | 37.62% |
| 2012 | 25.32 Million SGD | 17.63% |
| 2011 | 21.53 Million SGD | 17.9% |
| 2010 | 18.26 Million SGD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 17.92 Million USD | 169.98% |
| 2023 Q1 | 7.19 Million SGD | -62.36% |
| 2023 FY | 37.3 Million SGD | 0.31% |
| 2023 Q2 | 18.75 Million USD | 160.67% |
| 2023 Q3 | 6.63 Million SGD | -64.6% |
| 2022 Q1 | 6.48 Million SGD | -67.96% |
| 2022 Q2 | 17.17 Million USD | 164.83% |
| 2022 Q3 | 6.82 Million SGD | -60.25% |
| 2022 FY | 37.18 Million USD | 30.18% |
| 2022 Q4 | 19.11 Million USD | 179.99% |
| 2021 Q4 | 20.24 Million SGD | 165.78% |
| 2021 Q3 | 7.61 Million SGD | -46.21% |
| 2021 FY | 28.56 Million SGD | -2.88% |
| 2021 Q1 | 6.98 Million SGD | -52.4% |
| 2021 Q2 | 14.15 Million SGD | 102.59% |
| 2020 Q1 | 5.78 Million SGD | -48.24% |
| 2020 Q4 | 14.68 Million SGD | 69.49% |
| 2020 FY | 29.41 Million SGD | 2.81% |
| 2020 Q3 | 8.66 Million SGD | -45.25% |
| 2020 Q2 | 15.82 Million SGD | 173.34% |
| 2019 Q1 | 11.18 Million SGD | 70.52% |
| 2019 FY | 28.6 Million SGD | -21.41% |
| 2019 Q4 | 11.18 Million SGD | 13.03% |
| 2019 Q3 | 9.89 Million SGD | -8.47% |
| 2019 Q2 | 10.8 Million SGD | -3.34% |
| 2018 Q3 | 11.12 Million SGD | -6.86% |
| 2018 Q2 | 11.94 Million SGD | 0.66% |
| 2018 Q4 | 6.55 Million SGD | -41.03% |
| 2018 FY | 36.4 Million SGD | -20.45% |
| 2018 Q1 | 11.86 Million SGD | 8.35% |
| 2017 Q2 | 10.55 Million SGD | 14.59% |
| 2017 Q3 | 11.01 Million SGD | 4.32% |
| 2017 FY | 45.76 Million SGD | 21.91% |
| 2017 Q1 | 9.21 Million SGD | -3.64% |
| 2017 Q4 | 10.94 Million SGD | -0.58% |
| 2016 Q4 | 9.56 Million SGD | 0.65% |
| 2016 Q2 | 10.31 Million SGD | 5.74% |
| 2016 FY | 37.53 Million SGD | -3.08% |
| 2016 Q1 | 9.75 Million SGD | 3.39% |
| 2016 Q3 | 9.49 Million SGD | -7.91% |
| 2015 Q1 | 9.79 Million SGD | 4.19% |
| 2015 Q4 | 9.43 Million SGD | -5.27% |
| 2015 Q3 | 9.95 Million SGD | -15.37% |
| 2015 Q2 | 11.76 Million SGD | 20.13% |
| 2015 FY | 38.73 Million SGD | 31.04% |
| 2014 FY | 29.55 Million SGD | -15.21% |
| 2014 Q4 | 9.4 Million SGD | 3.76% |
| 2014 Q3 | 9.06 Million SGD | -8.78% |
| 2014 Q2 | 9.93 Million SGD | 13.66% |
| 2014 Q1 | 8.73 Million SGD | 4.61% |
| 2013 Q1 | 5.02 Million SGD | -24.57% |
| 2013 FY | 34.85 Million SGD | 37.62% |
| 2013 Q3 | 7.83 Million SGD | -11.64% |
| 2013 Q2 | 8.86 Million SGD | 76.46% |
| 2013 Q4 | 8.35 Million SGD | 6.61% |
| 2012 Q1 | 4.79 Million SGD | -3.36% |
| 2012 FY | 25.32 Million SGD | 17.63% |
| 2012 Q2 | 5.38 Million SGD | 12.22% |
| 2012 Q3 | 6.09 Million SGD | 13.25% |
| 2012 Q4 | 6.66 Million SGD | 9.3% |
| 2011 Q4 | 4.96 Million SGD | -1.43% |
| 2011 Q2 | 5.03 Million SGD | 13.63% |
| 2011 Q1 | 4.43 Million SGD | 0.0% |
| 2011 FY | 21.53 Million SGD | 17.9% |
| 2011 Q3 | 5.03 Million SGD | -0.04% |
| 2010 FY | 18.26 Million SGD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 19429.016% |
| Arrayit Corporation | 2.57 Million USD | -1348.705% |
| Atlantic International Corp. | -154.23 Thousand USD | 24287.274% |
| Biocept, Inc. | -2.58 Million USD | 1544.81% |
| Bioqual, Inc. | 7.42 Million USD | -402.145% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -13416.304% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.447% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -1979.332% |
| iMD Companies, Inc. | -23.63 Thousand USD | 157924.597% |
| IDenta Corp. | 662.97 Thousand USD | -5526.909% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -61.893% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -47991.426% |
| InVitro International | 635.98 Thousand USD | -5765.704% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -468.414% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -3314.07% |
| NovelStem International Corp. | 12 Thousand USD | -310775.0% |
| Optigenex Inc. | -102.96 Thousand USD | 36330.406% |
| PharmChem, Inc. | 3.9 Million USD | -855.466% |
| Proteome Sciences plc | 2.09 Million USD | -1679.283% |
| Response Genetics, Inc | 3.94 Million USD | -846.347% |
| Rennova Health, Inc. | 6.26 Million USD | -495.142% |
| RushNet, Inc. | 1.1 Million USD | -3277.195% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -4255.14% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 9339.697% |
| Todos Medical Ltd. | 4.31 Million USD | -765.545% |